Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Neuropeptide Y for PTSD and ASD
NCT04071600Phase 2Unknown
- Sponsor
- New York Medical College
- Start
- Nov 2019
- Primary completion
- Oct 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of neuropeptide Y (1-36) in post-traumatic stress disorder (PTSD), acute stress disorder (ASD), sponsored by New York Medical College. Status: unknown.
02
Drugs
neuropeptide Y (1-36)
03
Conditions
post-traumatic stress disorder (PTSD)acute stress disorder (ASD)
Beyond the preview
Go deeper on NCT04071600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04071600.